The hospital staffing crunch that throttled medical device gross sales in the latest quarters has eased, in accordance to
Johnson & Johnson
main economic officer, sending method volumes again up, and leading to an 8.1% raise in modified operational product sales in the company’s professional medical units division in the past quarter.
Johnson & Johnson (ticker: JNJ) posted altered earnings of $2.55 a share early Tuesday, on sales of $23.8 billion. Analysts surveyed by FactSet had anticipated the health care huge to report earnings of $2.48 a share on profits of about $23.4 billion.
The hospital staffing crunch that throttled medical device gross sales in the latest quarters has eased, in accordance to
Johnson & Johnson
main economic officer, sending method volumes again up, and leading to an 8.1% raise in modified operational product sales in the company’s professional medical units division in the past quarter.
Johnson & Johnson (ticker: JNJ) posted altered earnings of $2.55 a share early Tuesday, on sales of $23.8 billion. Analysts surveyed by FactSet had anticipated the health care huge to report earnings of $2.48 a share on profits of about $23.4 billion.
